Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium Ion SCHEMBL28700682 | 0.97 | CA4 (0.44) | — | |
| SCHEMBL31560796 | 0.93 | CASP1 (0.30) | — | |
| Potassium Ion SCHEMBL4855093 | 0.93 | — | — | |
| SCHEMBL4850698 | 0.93 | CASP1 (0.30) | — | |
| SCHEMBL4851288 | 0.93 | CASP1 (0.30) | — | |
| SCHEMBL31693522 | 0.86 | — | — | |
| SCHEMBL28610481 | 0.83 | CA4 (0.35) | — | |
| SCHEMBL4856888 | 0.78 | CASP1 (0.32) | — | |
| Tribromoacetic Acid SCHEMBL2079154 | 0.78 | CA4 (0.39) | — | |
| SCHEMBL4853842 | 0.78 | CASP1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025096782-A1 | FLUORINATED CANNABINOID COMPOSITIONS AND METHODS THEREOF | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2025-05-08 | — | — | WO | claimed |
| CN-119661449-A | Preparation method of 5- (difluoromethoxy) pyrazine-2-amine | 无锡捷化医药科技有限公司 | 2025-03-21 | — | — | CN | claimed |
| US-20220162227-A1 | METHODS FOR THE PREPARATION OF 1,3-BENZODIOXOLE HETEROCYCLIC COMPOUNDS | UNION therapeutics A/S (DK) | 2022-05-26 | — | — | US | claimed |
| EP-4027995-B1 | HPK1 ANTAGONISTS AND USES THEREOF | NIMBUS SATURN INC (US) | 2026-05-27 | — | — | EP | disclosed |
| CN-122094943-A | Novel 1,2, 4-oxadiazoles as fungicides | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260138956-A1 | NOVEL COMPOUNDS AND USES THEREOF | RECURSION PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-12610949-B2 | Heteroaryl-triazole compounds as pesticides | BAYER AKTIENGESELLSCHAFT (DE) | 2026-04-28 | — | — | US | disclosed |
| US-20260109715-A1 | IMIDAZOPYRIDINE DERIVATIVES WITH BICYCLIC STRUCTURE | PUBLIC UNIVERSITY CORPORATION YOKOHAMA CITY UNIVERSITY (JP) | 2026-04-23 | — | — | US | disclosed |
| EP-4688154-A1 | MORPHOLINE OREXIN RECEPTOR ANTAGONISTS | BIAL - Portela & Ca., S.A. (PT) | 2026-02-11 | — | — | EP | disclosed |
| US-20260035341-A1 | FTO INHIBITORS | RPXDS CO LTD (CN) | 2026-02-05 | — | — | US | disclosed |
| US-20260027113-A1 | PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE | SOLEY THERAPEUTICS INC (US) | 2026-01-29 | — | — | US | disclosed |
| EP-2522648-A1 | PROCESS FOR PRODUCING DIFLUOROCYCLOPROPANE COMPOUND | Central Glass Company, Limited (JP) | 2012-11-14 | — | — | EP | disclosed |
| EP-2519508-A2 | METALLOENZYME INHIBITOR COMPOUNDS | Viamet Pharmaceuticals, Inc. (US) | 2012-11-07 | — | — | EP | disclosed |
| US-20120277458-A1 | METHOD FOR PRODUCING DIFLUOROCYCLOPROPANE COMPOUND | CENTRAL GLASS COMPANY, LIMITED (JP) | 2012-11-01 | — | — | US | disclosed |
| US-20120277458-A1 | METHOD FOR PRODUCING DIFLUOROCYCLOPROPANE COMPOUND | CENTRAL GLASS COMPANY, LIMITED (JP) | 2012-11-01 | — | — | US | disclosed |
| JP-2011140474-A | METHOD FOR PRODUCING DIFLUOROCYCLOPROPANE COMPOUND | CENTRAL GLASS CO LTD | 2011-07-21 | — | — | JP | disclosed |
| WO-2011083612-A1 | PROCESS FOR PRODUCING DIFLUOROCYCLOPROPANE COMPOUND | セントラル硝子株式会社 (JP) | 2011-07-14 | — | — | WO | disclosed |
| WO-2011082245-A2 | METALLOENZYME INHIBITOR COMPOUNDS | VIAMET PHARMACEUTICALS, INC. (US) | 2011-07-07 | — | — | WO | disclosed |
| US-7414148-B2 | Process for producing alkoxycarbonylfluoroalkanesulfonates | CENTRAL GLASS COMPANY LIMITED (JP) | 2008-08-19 | — | — | US | disclosed |
| US-20080108846-A1 | PROCESS FOR PRODUCING ALKOXYCARBONYLFLUOROALKANESULFONATES | CENTRAL GLASS COMPANY, LIMITED (JP) | 2008-05-08 | — | — | US | disclosed |